Telomir Pharmaceuticals is pursuing global licensing and strategic partnerships after FDA cleared its IND for Telomir-Zn in advanced or metastatic triple-negative breast cancer. The company will pitch the program at BioJapan2026 and upcoming Tokyo data events.
published
Telomir Pharmaceuticals is pursuing global licensing and strategic partnerships after FDA cleared its IND for Telomir-Zn in advanced or metastatic triple-negative breast cancer. The company will pitch the program at BioJapan2026 and upcoming Tokyo data events.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.